<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00817973</url>
  </required_header>
  <id_info>
    <org_study_id>CERN-PPL (5A) LSM</org_study_id>
    <nct_id>NCT00817973</nct_id>
  </id_info>
  <brief_title>Differential Effects of Protein Quality on Postprandial Lipemia in Response to a Fat-Rich Meal in Type 2 Diabetes: Comparison of Whey, Casein, Gluten, and Cod Protein</brief_title>
  <official_title>Differential Effects of Protein Quality on Postprandial Lipemia in Response to a Fat-Rich Meal in Type 2 Diabetes: Comparison of Whey, Casein, Gluten, and Cod Protein</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Danish Obesity Research Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nordic Centre of Excellence</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aarhus University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Enhanced and prolonged postprandial triglyceride responses involve increased cardiovascular
      risk in type 2 diabetes. It has been demonstrated that dietary fat and carbohydrates
      profoundly influence postprandial hypertriglyceridemia in type 2 diabetes, whereas little
      information exists about the effect of proteins.

      The purpose of this study is to compare the effects of the proteins casein, whey, cod, and
      gluten on postprandial lipid and incretin responses to a high-fat meal in type 2 diabetes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Triglyceride levels</measure>
    <time_frame>0h- 2h- 4h- 6h- 7h- 8h postprandial</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incretin levels</measure>
    <time_frame>0h- 0.5h- 1h- 2h- 4h- 6h- 8h postprandial</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Type 2 Diabetes</condition>
  <condition>Postprandial Lipemia</condition>
  <arm_group>
    <arm_group_label>Casein</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Whey</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Cod</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Gluten</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Casein</intervention_name>
    <arm_group_label>Casein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Whey</intervention_name>
    <arm_group_label>Whey</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cod</intervention_name>
    <arm_group_label>Cod</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Gluten</intervention_name>
    <arm_group_label>Gluten</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diabetes

        Exclusion Criteria:

          -  Liver, Kidney- and/or Heart Disease

          -  Serious Hypertension (160/110 mmHg)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kjeld Hermansen, Professor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Endocrinology and Metabolism</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Clinical Nutrition</name>
      <address>
        <city>Aarhus</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 6, 2009</study_first_submitted>
  <study_first_submitted_qc>January 6, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2009</study_first_posted>
  <last_update_submitted>January 8, 2009</last_update_submitted>
  <last_update_submitted_qc>January 8, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 9, 2009</last_update_posted>
  <responsible_party>
    <name_title>Kjeld Hermansen, Professor, Chief Physician, MD, Dr.Med.Sci</name_title>
    <organization>Department of Endocrinology and Metabolism, Aarhus University Hospital</organization>
  </responsible_party>
  <keyword>Whey protein</keyword>
  <keyword>gluten</keyword>
  <keyword>casein</keyword>
  <keyword>cod protein</keyword>
  <keyword>GLP-1</keyword>
  <keyword>postprandial</keyword>
  <keyword>triglyceride</keyword>
  <keyword>free fatty acids</keyword>
  <keyword>chylomicrons</keyword>
  <keyword>retinyl palmitate</keyword>
  <keyword>type 2 diabetes</keyword>
  <keyword>GIP</keyword>
  <keyword>Postprandial incretins</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Hyperlipidemias</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caseins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

